Click here to download your blank USDA VS16-3 form
 Word 97 USDA VS16-3 document

Required to obtain USDA Permit 
(one of 4 FDA required documents)

PLEASE PRINT OR TYPE CLEARLY

No controlled material, organisms or vectors may be imported or moved interstate unless the data requested on this form is furnished and certified (9 CFR 94, 95 and 122). Public reporting burden for this collection of information is estimated to average between 1.6 and 3 hours per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to Department of Agriculture, Clearance Officer, OIRM, Room 404-W, Washington, DC 20250; and to the Office of Information and Regulatory Affairs, Office of Management and Budget, Washington, DC 20503.

U.S. DEPARTMENT OF AGRICULTURE
ANIMAL AND PLANT HEALTH INSPECTION SERVICE
VETERINARY SERVICES
National Center for Import-Export, Products Program
4700 River Road, Unit 40
Riverdale, MD 20737-1231

APPLICATION FOR PERMIT TO:
IMPORT CONTROLLED MATERIAL
IMPORT OR TRANSPORT ORGANISMS OR VECTORS

FORM APPROVED – OMB NO. 0579-0015


1. MODE OF TRANSPORTATION (Please Check):

_X_ AIR ___ SEA ___ LAND ___ ANY


2. U.S Ports of Entry

_X_ New York, NY (JFK International Airport)
_
X_ Chicago, IL (Ohare International Airport)
_
X_ Determined by Shipper

  4. SHIPPER: (Name and Address of foreign producer)

Wockhardt Ltd. UK
Ash Road North, Wrexham Industrial Estate,
Wrexham, LL 13 9 UF, United Kingdom
Phone: +44-1978-6611261 FAX: +44-1978-660130

5. DESCRIPTION: (material, country of origin, animal source, recombinant system & genetic inserts conditions of imported preparation, antibody immunogens, etc.) (COMPLETE VS FORM 16-7 for cell cultures & their products)

This application is for permit to import insulin pharmaceutical products for the treatment of Diabetes Mellitus on a "personal use basis" as follows:

Material: Highly Purified, Pharmaceutical Grade Bovine Insulin (certified from BSE-Free sources recognized by the European Union)
Country of Origin: United Kingdom
Animal Source: Highly purified pharmaceutical grade Bovine Pancreatic Extract as described above – (*Eli Lilly Iletin® designations below are provided for information as to which UK names have the most similar actions.)

Description of items to be imported: ------------------------------------------- Strength and Packaging:
___ Hypurin® Bovine Neutral (*US Iletin® I Regular) Insulin | . . . | ___ 100 IU/CC – 10CC Vials
___ Hypurin® Bovine Isophane (*US Iletin® I NPH) Insulin
| . . . . | ___ 100 IU/CC – 1.5 to 3CC Cartridges if available
___ Hypurin® Bovine Lente (*US Iletin® I Lente®) Insulin
___ Hypurin® Bovine Protamine Zinc (*US Iletin® I UL or PZI) Insulin

6. QUANTITY AND FREQUENCY OF IMPORTATIONS (estimate))

___ Monthly ___ Quarterly
___ Hypurin® Bovine Neutral Insulin ____________________________________________
___ Hypurin® Bovine Isophane Insulin ___________________________________________
___ Hypurin® Bovine Lente Insulin ______________________________________________
___ Hypurin® Bovine Protamine Zinc Insulin ______________________________________

I certify that the amounts above are for personal use only and are insufficient quantities for any non-personal or commercial use and 3mos or less supply.

7. PROPOSED USE OF MATERIAL, EXPECTED COMPLETION DATE, AND FINAL DISPOSITION (method)

Proposed use: Personal use importation of insulin medication for treatment of Diabetes Mellitus, Patient Name(s)
Expected Completion Date: Duration of personal uses natural life of patient or return of licensed distribution for the needed insulins to the US market.
Final Disposition: Medications will be injected as instructed by US medical team treating patient.

I certify that Doctor ________________ practicing at ______________________, Phone:___________, has indicated that available porcine and human insulins are not appropriate to control the diabetes mellitus condition of __________________________.

8. DESCRIPTION OF APPLICANT’S FACILITIES AND EQUIPMENT FOR HANDLING MATERIALS:

Insulin will be used in the personal use’s home for the personal treatment of diabetes mellitus as directed by patients medical doctor.

9. QUALIFICATIONS OF TECHNICAL PERSONNEL WORKING WITH THIS MATERIAL (if applicable)
Not applicable, personal use on medical need basis.
10. TREATMENT OF MATERIAL PRIOR TO IMPORTATION (Processing/purification methods, treatments, disease safeguards)
Purification process consists of solvent/chemical extraction from pancreatic tissue with crude eluate fractionated by gel chromatography and crystallization. The insulin crystals are then dissolved and purified by filtration followed by anion chromatography and subsequent crystallization to produce highly purified monocomponent insulin. Cattle pancreas material used for the production of Bovine insulin is certified by the producer to come from countries recognized by the European Union as BSE-free. Insulin is refrigerated as it is diluted to appropriate designated bioactivity and activity type and while in storage and transit.
11. WORK OBJECTIVES, PROPOSED PLAN OR WORK, AND ADDITIONAL PERTINENT INFORMATION (animal model, use of derivatives, etc.)
Maintenance of reasonable glycemic control with minimal hypoglycemia and other problems for the personal use of the patient. Not applicable.
12. PERTINENT PUBLISHED PAPER/ABSTRACT REGARDING MATERIAL TO BE IMPORTED – ATTACH COPY IF AVAILABLE

1. "Biologic Activities of Biosynthetic Human Insulin in Healthy Volunteers and Insulin-dependent Diabetic Patients Monitored by the Artificial Endocrine Pancreas" Sotos Raptis, et al, DIAB CARE, Vol. 4, No. 2, p. 161, March-April 1981
2. "HYPOGLYCEMIA UNAWARENESS IN DIABETICS TRANSFERRED FROM BEEF/PORCINE INSULIN TO HUMAN INSULIN" A. Teuscher and W. G. Berger, LANCET, p. 382-85, August 15,1987
3. "Failure of warning in insulin induced hypoglycemic reactions" K. E. Sussman, et al, DIABETES, 1963; 12: 38-45
4. "'HUMAN' INSULIN LOSES ITS CLEAN APPEAL~ Frank Lesser, N~W SCIENTIST, p. 30, April 15, 1989
5. "HUMAN INSULIN COMES UNDER CLOSE SCRUTINY AS NUMBER OF DEATHS RISE" Frank Lesser, NEW SCIENTIST, p. 22 August 19, 1989
7. "REPORTS OF DEATHS AMONG U.K. DIABETICS USING HUMAN INSULIN STIR CONCERN HERE" Bill Richards, WALL STREET JOURNAL, Metro DC edition sometime in or near the week of 10/23-30/89
8. "RESPONSES TO HUMAN AND PORCINE INSULIN IN HEALTHY SUBJECTS" R.J. Heine, et al, LANCET, p. 946-49, October 21,1989

I CERTIFY THIS MATERIAL WILL BE USED IN ACCORDANCE WITH ALL RESTRICTIONS AND PRECAUTIONS AS MAY BE SPECIFIED IN THE PERMIT
13. SIGNATURE OF APPLICANT

 

14. TYPED NAME AND TITLE
15. DATE 16. APHIS USE CREDIT ACCOUNT NUMBER and EXPIRATION DATE:

 


You may now apply for permits  and renew permits online at: https://web01.aphis.usda.gov/ias.nsf/Mainform?OpenForm

 

IMPORTANT!  The address you use on the application for permit must be the same as where your insulin will be sent to.  NO P.O. boxes are allowed.  

*Be sure to include your social security number beside your name.

As of this writing there is no fee for beef or pork insulin permit applications, but this could change.  So, you might want to check with the USDA.

The USDA issued insulin permit is good for  5 years and as of this time there is no fee for renewals.   

You may now apply for permits  and renew permits online at: https://web01.aphis.usda.gov/ias.nsf/Mainform?OpenForm

What goes in mode of transportation? AIR

                    Port of entry? Determined by shipper

                    Description? Beef Insulin

                    Quantity, Frequency? Personal Use, ~2 shipments per year, ~20 10cc vials each shipment,

                    Proposed use? Treatment of diabetes in importer

                    Item 8 doesn't apply? Insulin will be used in the personal user’s home for the personal treatment of diabetes mellitus as directed by patients medical doctor.

                   Treatment of material? Purification process consists of solvent/chemical extraction from pancreatic tissue with crude eluate fractionated by liquid or gel chromatography and crystallization. The insulin crystals are then dissolved and purified by filtration followed by anion chromatography and subsequent crystallization to produce highly purified monocomponent insulin. Cattle pancreas material used for the production of Bovine insulin is certified by the producer to come from countries recognized by the European Union as BSE-free. Insulin is refrigerated as it is diluted to appropriate designated bioactivity and activity type and while in storage and transit.

                       Method of Final Disposition? Injected into importer.

Resulting USDA Permit (Form 16-6A)

USDA Import Permit, Doctor’s Certificate of Medical Necessity, CP Pharmaceuticals/Wockhardt, Ltd. UK ADR form, and Personal Certificate of personal use and 6 month, or less supply